Skip to main content
Premium Trial:

Request an Annual Quote

FDA Issues Emergency Use Authorization for PerkinElmer's Euroimmun SARS-CoV-2 Test

NEW YORK – The US Food and Drug Administration on Monday issued Emergency Use Authorization to Euroimmun's EuroRealTime SARS-CoV-2 molecular assay COVID-19.

The PCR-based test is for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens, including nasal, nasopharyngeal, mid-turbinate, and oropharyngeal swabs, as well as bronchioalveolar lavage from patients who are suspected of having COVID-19.

The test, which also has the CE mark, is the second from Euroimmun, a subsidiary of PerkinElmer, to receive EUA from the FDA. In early May, the Lübeck, Germany-based firm's US subsidiary's IgG antibody test was granted EUA. 

PerkinElmer's RT-PCR test for the coronavirus also was granted EUA in March.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.